Article Details

GT Biopharma Announces GTB-3550 TriKE(TM) Reduces Bone Marrow Blast Levels, Improves NK ...

Retrieved on: 2020-12-08 12:33:45

Tags for this article:

Click the tags to see associated articles and topics

GT Biopharma Announces GTB-3550 TriKE(TM) Reduces Bone Marrow Blast Levels, Improves NK .... View article details on hiswai:

Excerpt

BEVERLY HILLS, CA / ACCESSWIRE / December 8, 2020 / GT <b>Biopharma</b>, Inc. (OTCQB:GTBP)(GTBP.PA) an immuno-oncology company focused on ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up